The Immune Assessment of PD-1 Antibody Therapy in Tumor

Recruiting now

Conditions studied: Efficacy, Team, Adverse Event

In brief

This retrospective study will leverage previous immune function monitoring results in conjunction with clinical case data at this medical center.

Key facts

Study ID

NCT06693440

Run by

Quanli Gao

People needed

3000

Starts

2021-07-01

Expected to finish

2030-11-13

Last updated by the study team

2024-11-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥18 years.
• Pathologically confirmed malignant tumors.
• Complete medical records.
• Assessable immune function test data.

You may not qualify if…

• Age <18 years.
• No confirmed tumor pathology.
• Untraceable medical records.
• Non-assessable immune function tests.

Where it is running

• Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital — Zhengzhou, Henan, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.